Equillium Cash from Investing (Quarterly) Analysis

Equillium Inc (EQ)

0.6842 -0.10 (-12.33%) USD | NASDAQ | Nov 14, 16:00

0.6704 -0.01 (-2.02%) After-Hours: 05:37

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
June 30, 2024	-1.351M
March 31, 2024	-2.831M
December 31, 2023	-5.566M
September 30, 2023	10.98M
June 30, 2023	15.00M
March 31, 2023	-25.18M
December 31, 2022	6.978M
September 30, 2022	15.00M
June 30, 2022	8.691M
March 31, 2022	-11.98M
December 31, 2021	-16.89M
September 30, 2021	10.47M
June 30, 2021	28.97M

Date	Value
March 31, 2021	4.86M
December 31, 2020	-17.04M
September 30, 2020	-23.02M
June 30, 2020	8.455M
March 31, 2020	13.00M
December 31, 2019	-5.33M
September 30, 2019	-0.225M
June 30, 2019	6.04M
March 31, 2019	-2.651M
December 31, 2018	-37.41M
September 30, 2018	-0.003M
June 30, 2018	-0.017M
March 31, 2018	-0.005M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-25.18M

Minimum

Mar 2023

28.97M

Maximum

Jun 2021

0.696M

Average

4.86M

Median

Mar 2021

Cash from Investing (Quarterly) Benchmarks

Matinas BioPharma Holdings Inc	-2.938M
Tenon Medical Inc	0.00
Alphatec Holdings Inc	-19.88M
Madrigal Pharmaceuticals Inc	-202.39M
Spero Therapeutics Inc	--

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	0.73M
Cash from Financing (Quarterly)	0.091M
Free Cash Flow	-15.77M
Free Cash Flow Per Share (Quarterly)	0.0183
Free Cash Flow to Equity (Quarterly)	0.668M
Free Cash Flow to Firm (Quarterly)	0.668M
Free Cash Flow Yield	-65.00%